These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35016221)

  • 1. Commentary: Role and communications of cancer hazard determinations.
    Samet JM; Berrington de Gonzalez A; Lunn RM; Schubauer-Berigan MK
    Carcinogenesis; 2022 Mar; 43(2):79-81. PubMed ID: 35016221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: IARC Monographs Program and public health under siege by corporate interests.
    Infante PF; Melnick R; Vainio H; Huff J
    Am J Ind Med; 2018 Apr; 61(4):277-281. PubMed ID: 29397007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IARC monographs: critics and controversy.
    Samet JM
    Carcinogenesis; 2015 Jul; 36(7):707-9. PubMed ID: 25943987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key characteristics of 86 agents known to cause cancer in humans.
    Krewski D; Bird M; Al-Zoughool M; Birkett N; Billard M; Milton B; Rice JM; Grosse Y; Cogliano VJ; Hill MA; Baan RA; Little J; Zielinski JM
    J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):244-263. PubMed ID: 31637961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritizing cancer hazard assessments for IARC Monographs using an integrated approach of database fusion and text mining.
    Barupal DK; Schubauer-Berigan MK; Korenjak M; Zavadil J; Guyton KZ
    Environ Int; 2021 Nov; 156():106624. PubMed ID: 33984576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble.
    Baan RA; Straif K
    ALTEX; 2022; 39(3):443–450. PubMed ID: 34164695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritizing Chemicals for Risk Assessment Using Chemoinformatics: Examples from the IARC Monographs on Pesticides.
    Guha N; Guyton KZ; Loomis D; Barupal DK
    Environ Health Perspect; 2016 Dec; 124(12):1823-1829. PubMed ID: 27164621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.
    Samet JM; Chiu WA; Cogliano V; Jinot J; Kriebel D; Lunn RM; Beland FA; Bero L; Browne P; Fritschi L; Kanno J; Lachenmeier DW; Lan Q; Lasfargues G; Le Curieux F; Peters S; Shubat P; Sone H; White MC; Williamson J; Yakubovskaya M; Siemiatycki J; White PA; Guyton KZ; Schubauer-Berigan MK; Hall AL; Grosse Y; Bouvard V; Benbrahim-Tallaa L; El Ghissassi F; Lauby-Secretan B; Armstrong B; Saracci R; Zavadil J; Straif K; Wild CP
    J Natl Cancer Inst; 2020 Jan; 112(1):30-37. PubMed ID: 31498409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IARC monographs: 40 years of evaluating carcinogenic hazards to humans.
    Pearce N; Blair A; Vineis P; Ahrens W; Andersen A; Anto JM; Armstrong BK; Baccarelli AA; Beland FA; Berrington A; Bertazzi PA; Birnbaum LS; Brownson RC; Bucher JR; Cantor KP; Cardis E; Cherrie JW; Christiani DC; Cocco P; Coggon D; Comba P; Demers PA; Dement JM; Douwes J; Eisen EA; Engel LS; Fenske RA; Fleming LE; Fletcher T; Fontham E; Forastiere F; Frentzel-Beyme R; Fritschi L; Gerin M; Goldberg M; Grandjean P; Grimsrud TK; Gustavsson P; Haines A; Hartge P; Hansen J; Hauptmann M; Heederik D; Hemminki K; Hemon D; Hertz-Picciotto I; Hoppin JA; Huff J; Jarvholm B; Kang D; Karagas MR; Kjaerheim K; Kjuus H; Kogevinas M; Kriebel D; Kristensen P; Kromhout H; Laden F; Lebailly P; LeMasters G; Lubin JH; Lynch CF; Lynge E; 't Mannetje A; McMichael AJ; McLaughlin JR; Marrett L; Martuzzi M; Merchant JA; Merler E; Merletti F; Miller A; Mirer FE; Monson R; Nordby KC; Olshan AF; Parent ME; Perera FP; Perry MJ; Pesatori AC; Pirastu R; Porta M; Pukkala E; Rice C; Richardson DB; Ritter L; Ritz B; Ronckers CM; Rushton L; Rusiecki JA; Rusyn I; Samet JM; Sandler DP; de Sanjose S; Schernhammer E; Costantini AS; Seixas N; Shy C; Siemiatycki J; Silverman DT; Simonato L; Smith AH; Smith MT; Spinelli JJ; Spitz MR; Stallones L; Stayner LT; Steenland K; Stenzel M; Stewart BW; Stewart PA; Symanski E; Terracini B; Tolbert PE; Vainio H; Vena J; Vermeulen R; Victora CG; Ward EM; Weinberg CR; Weisenburger D; Wesseling C; Weiderpass E; Zahm SH
    Environ Health Perspect; 2015 Jun; 123(6):507-14. PubMed ID: 25712798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.
    Huff J
    Int J Occup Environ Health; 2002; 8(3):249-70. PubMed ID: 12358081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years of using key characteristics of human carcinogens to organize and evaluate mechanistic evidence in IARC Monographs on the identification of carcinogenic hazards to humans: Patterns and associations.
    Rusyn I; Wright FA
    Toxicol Sci; 2024 Feb; 198(1):141-154. PubMed ID: 38141214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the International Agency for Research on Cancer's consideration of mechanistic evidence.
    Goodman J; Lynch H
    Toxicol Appl Pharmacol; 2017 Mar; 319():39-46. PubMed ID: 28162991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False positives in cancer epidemiology.
    McLaughlin JK; Tarone RE
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):11-5. PubMed ID: 23118145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking environmental cancer with occupational epidemiology research: the role of the International Agency for Research on Cancer (IARC).
    Goldsmith DF
    J Environ Pathol Toxicol Oncol; 2000; 19(1-2):171-5. PubMed ID: 10905524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycotoxins as human carcinogens-the IARC Monographs classification.
    Ostry V; Malir F; Toman J; Grosse Y
    Mycotoxin Res; 2017 Feb; 33(1):65-73. PubMed ID: 27888487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program.
    Goodman JE; Mayfield DB; Becker RA; Hartigan SB; Erraguntla NK
    Regul Toxicol Pharmacol; 2020 Jun; 113():104639. PubMed ID: 32147291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [International Agency for Research on Cancer Monographs (IARC)].
    Terracini B
    G Ital Med Lav Ergon; 2008; 30(1):83; author reply 86-7. PubMed ID: 18700682
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of biological mechanisms of human carcinogens.
    Birkett N; Al-Zoughool M; Bird M; Baan RA; Zielinski J; Krewski D
    J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):288-359. PubMed ID: 31631808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [International Agency for Research on Cancer Monographs (IARC)].
    Pirastu R; Biggeri A; Comba P
    G Ital Med Lav Ergon; 2008; 30(1):83-4; author reply 86-7. PubMed ID: 18705061
    [No Abstract]   [Full Text] [Related]  

  • 20. Man-made mineral (vitreous) fibres: evaluations of cancer hazards by the IARC Monographs Programme.
    Baan RA; Grosse Y
    Mutat Res; 2004 Sep; 553(1-2):43-58. PubMed ID: 15288532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.